SEC 13F Intelligence

Endurant Capital Management LP / MRNA

Endurant Capital Management LP’s Moderna Inc Position

Does Endurant Capital Management LP own Moderna Inc (MRNA)? Not currently — the last reported position was 36.1K shares worth $6M in Q1 2023; the fund’s latest 13F (Q1 2024) no longer reports it.

Position Value
$6M
Q1 2023
Shares
36.1K
% of Portfolio
+2.85%
Quarters Held
1
position exited

Position History MRNA

Reported value by quarter
Q1 ’23: $6MQ1 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202336.1K$6M+2.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurant Capital Management LP’s full portfolio or all institutional holders of MRNA.